Research Paper Volume 15, Issue 5 pp 1524—1542

High expression of TARS is associated with poor prognosis of endometrial cancer

class="figure-viewer-img"

Figure 9. Predictive value of TARS expression in disease specific survival. (A, B) ROC curves evaluating the TARS expression for predicting disease specific survival. (C) Nomogram predicted 1-year disease specific survival vs. actual 1-year disease specific survival. (D) Nomogram predicted 3-year disease specific survival vs. actual 3-year disease specific survival. (E) Nomogram predicted 5-year disease specific survival vs. actual 5-year disease specific survival. (FH) Decision curve analysis reflects the feasibility of TARS expression in predicting 1-year, 3-year, and 5-year disease specific survival.